Patent classifications
C12Y207/07019
METHODS AND APPARATUS FOR SYNTHESIZING NUCLEIC ACIDS
The invention provides improved methods for synthesizing polynucleotides, such as DNA and RNA, using enzymes and specially designed nucleotide analogs. Using the methods of the invention, specific sequences of polynucleotides can be synthesized de nova, base by base, in an aqueous environment, without the use of a nucleic acid template. Because the nucleotide analogs have an unmodified 3 OH, i.e., as found in natural deoxyribose and ribose molecules, the analogs result in natural polynucleotides suitable for incorporation into biological systems.
NOVEL REGULATORY ELEMENT FOR ENHANCING RNA STABILITY OR MRNA TRANSLATION, ZCCHC2 INTERACTING THEREWITH, AND USE THEREOF
The present disclosure relates to a novel regulatory element for enhancing RNA stability or mRNA translation; ZCCHC2 interacting with the regulatory element; and uses thereof. Being capable of increasing the expression of a target protein, the novel regulatory element for enhancing RNA stability or mRNA translation; and ZCCHC2 interacting with regulatory element according to the present disclosure are applicable in various fields, depending on the uses of the target protein.
Enzyme based system for production of messenger RNA with increased transfection efficiency
A method for the production of proteins used in the in vitro transcription (IVT) of messenger RNA (mRNA), wherein the proteins are evaluated for purity and efficacy by the efficiency with which mRNA synthetically derived therefrom, subsequently transfects cells and produces encoded proteins.
POLYNUCLEOTIDE AND PRODUCING METHOD THEREOF
Disclosed are a polynucleotide with improved stability in vivo, a producing method thereof, and a method of improving the stability of polynucleotide in vivo.
Enzyme Based System for Production of Messenger RNA with Increased Transfection Efficiency
A method for the production of proteins used in the in vitro transcription (IVT) of messenger RNA (mRNA), wherein the proteins are evaluated for purity and efficacy by the efficiency with which mRNA synthetically derived therefrom, subsequently transfects cells and produces encoded proteins.